Matrix-based gene delivery for tissue repair

Current Opinion in Biotechnology

Volumn 24, Issue 5, 2013, Pages 855-863

  Cam, Cynthia ^a   Segura, Tatiana ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIGN PARAMETERS; GENE DELIVERY; PARACRINE; PROTEIN DELIVERY; THERAPEUTIC PROTEIN; TISSUE FORMATION; TISSUE REPAIR; TRANSGENE EXPRESSION;

GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; MACHINERY; PROTEINS; TISSUE;

SCAFFOLDS (BIOLOGY);

MOLECULAR SCAFFOLD; PLASMID DNA;

CELL INFILTRATION; CONTROLLED DRUG RELEASE; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; GENE TRANSFER; GENE VECTOR; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REPAIR; VIRAL GENE DELIVERY SYSTEM;

EID: 84884417614     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.04.007     Document Type: Review

References (63)

1. Bowen-Pope D.F., Malpass T.W., Foster D.M., Ross R. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. Blood 1984, 64:458-469.
2. Edelman E.R., Nugent M.A., Karnovsky M.J. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc Natl Acad Sci U S A 1993, 90:1513-1517.
3. Eppler S.M., Combs D.L., Henry T.D., Lopez J.J., Ellis S.G., Yi J.H., Annex B.H., McCluskey E.R., Zioncheck T.F. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther 2002, 72:20-32.
4. Simons M., Annex B.H., Laham R.J., Kleiman N., Henry T., Dauerman H., Udelson J.E., Gervino E.V., Pike M., Whitehouse M.J., Moon T., et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002, 105:788-793.
5. Simons M., Ware J.A. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov 2003, 2:863-871.
6. Henry T.D., Annex B.H., McKendall G.R., Azrin M.A., Lopez J.J., Giordano F.J., Shah P.K., Willerson J.T., Benza R.L., Berman D.S., Gibson C.M., et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003, 107:1359-1365.
7. Gauglitz G.G., Jeschke M.G. Combined gene and stem cell therapy for cutaneous wound healing. Mol Pharm 2011, 8:1471-1479.
8. Agarwal A., Mallapragada S.K. Synthetic sustained gene delivery systems. Curr Top Med Chem 2008, 8:311-330.
9. Lee S., Chen T.T., Barber C.L., Jordan M.C., Murdock J., Desai S., Ferrara N., Nagy A., Roos K.P., Iruela-Arispe M.L. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007, 130:691-703.
10. Huang M., Chen Z., Hu S., Jia F., Li Z., Hoyt G., Robbins R.C., Kay M.A., Wu J.C. Novel minicircle vector for gene therapy in murine myocardial infarction. Circulation 2009, 120(Suppl):S230-S237.
11. Wilber A., Frandsen J.L., Wangensteen K.J., Ekker S.C., Wang X., McIvor R.S. Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Hum Gene Ther 2005, 16:1325-1332.
12. Meilander-Lin N.J., Cheung P.J., Wilson D.L., Bellamkonda R.V. Sustained in vivo gene delivery from agarose hydrogel prolongs nonviral gene expression in skin. Tissue Eng 2005, 11:546-555.
13. Jafari M., Soltani M., Naahidi S.,N., Karunaratne D., Chen P. Nonviral approach for targeted nucleic acid delivery. Curr Med Chem 2012, 19:197-208.
14. Tros de Ilarduya C., Sun Y., Düzgüneş N. Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci 2010, 40:159-170.
15. Giacca M., Zacchigna S. Virus-mediated gene delivery for human gene therapy. J Control Release 2012, 161:377-388.
16. Bramfeld H., Sabra G., Centis V., Vermette P. Scaffold vascularization: a challenge for three-dimensional tissue engineering. Curr Med Chem 2010, 17:3944-3967.
17. Shea L.D., Smiley E., Bonadio J., Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999, 17:551-554.
18. Jang J.H., Rives C.B., Shea L.D. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther 2005, 12:475-483.
19. Avilés M.O., Lin C.-H., Zelivyanskaya M., Graham J.G., Boehler R.M., Messersmith P.B., Shea L.D. The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds. Biomaterials 2010, 31:1140-1147.
20. Kong H., Kim E., Huang Y.-C., Mooney D. Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res 2008, 25:1230-1238.
21. Shin S., Shea L.D. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther 2010, 18:700-706.
22. Kidd M.E., Shin S., Shea L.D. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo. J Control Release 2012, 157:80-85.
23. Raut S.D., Lei P., Padmashali R.M., Andreadis S.T. Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays. J Control Release 2010, 144:213-220.
24. Saito T., Tabata Y. Preparation of gelatin hydrogels incorporating small interfering RNA for the controlled release. J Drug Target 2012, 20:864-872.
25. Shepard J.A., Wesson P.J., Wang C.E., Stevans A.C., Holland S.J., Shikanov A., Grzybowski B.A., Shea L.D. Gene therapy vectors with enhanced transfection based on hydrogels modified with affinity peptides. Biomaterials 2011, 32:5092-5099.
26. Lei Y., Rahim M., Ng Q., Segura T. Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery. J Control Release 2011, 153:255-261.
27. Tokatlian T., Cam C., Siegman S.N., Lei Y., Segura T. Design and characterization of microporous hyaluronic acid hydrogels for in vitro gene transfer to mMSCs. Acta Biomater 2012, 8:3921-3931.
28. Lei Y., Segura T. DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells. Biomaterials 2009, 30:254-265.
29. Shepard J.A., Huang A., Shikanov A., Shea L.D. Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels. J Control Release 2010, 146:128-135.
30. Gojgini S., Tokatlian T., Segura T. Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels. Mol Pharm 2011, 8:1582-1591.
31. Lei Y.G., Huang S.X., Sharif-Kashani P., Chen Y., Kavehpour P., Segura T. Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials 2010, 31:9106-9116.
32. Shepard J.A., Virani F.R., Goodman A.G., Gossett T.D., Shin S., Shea L.D. Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials 2012, 33:7412-7421.
33. Trentin D., Hall H., Wechsler S., Hubbell J.A. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A 2006, 103:2506-2511.
34. Kim H.S., Yoo H.S. MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: in vitro and in vivo evaluation. J Control Release 2010, 145:264-271.
35. Tokatlian T., Shrum C.T., Kadoya W.M., Segura T. Protease degradable tethers for controlled and cell-mediated release of nanoparticles in 2- and 3-dimensions. Biomaterials 2010, 31:8072-8080.
36. Segura T., Chung P.H., Shea L.D. DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials 2005, 26:1575-1584.
37. Saul J.M., Linnes M.P., Ratner B.D., Giachelli C.M., Pun S.H. Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression. Biomaterials 2007, 28:4705-4716.
38. Chang P.C., Seol Y.J., Cirelli J.A., Pellegrini G., Jin Q., Franco L.M., Goldstein S.A., Chandler L.A., Sosnowski B., Giannobile W.V. PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration. Gene Ther 2009, 17:95-104.
39. Rose L.C., Kucharski C., Uludag H. Protein expression following non-viral delivery of plasmid DNA coding for basic FGF and BMP-2 in a rat ectopic model. Biomaterials 2012, 33:3363-3374.
40. Chang S.C.N., Chung H.-Y., Tai C.-L., Chen P.K.T., Lin T.-M., Jeng L.-B. Repair of large cranial defects by hBMP-2 expressing bone marrow stromal cells: comparison between alginate and collagen type I systems. J Biomed Mater Res A 2010, 94A:433-441.
41. Zhang Y., Wu C., Luo T., Li S., Cheng X., Miron R.J. Synthesis and inflammatory response of a novel silk fibroin scaffold containing BMP7 adenovirus for bone regeneration. Bone 2012, 51:704-713.
42. Tuinstra H.M., Aviles M.O., Shin S., Holland S.J., Zelivyanskaya M.L., Fast A.G., Ko S.Y., Margul D.J., Bartels A.K., Boehler R.M., Cummings B.J., et al. Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials 2012, 33:1618-1626.
43. Yang Y., Xia T., Chen F., Wei W., Liu C., He S., Li X. Electrospun fibers with plasmid bFGF polyplex loadings promote skin wound healing in diabetic rats. Mol Pharm 2011, 9:48-58.
44. Guo R., Xu S., Ma L., Huang A., Gao C. Enhanced angiogenesis of gene-activated dermal equivalent for treatment of full thickness incisional wounds in a porcine model. Biomaterials 2010, 31:7308-7320.
45. Luo T., Zhang W., Shi B., Cheng X., Zhang Y. Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery. Clin Oral Implants Res 2012, 23:467-473.
46. Khormaee S., Ali O.A., Chodosh J., Mooney D.J. Optimizing siRNA efficacy through alteration in the target cell-adhesion substrate interaction. J Biomed Mater Res A 2012, 100:2637-2643.
47. Orsi S., Guarnieri D., De Capua A., Netti P.A. Gene-activated and cell-migration guiding PEG matrices based on three dimensional patterning of RGD peptides and DNA complexes. Acta Biomater 2012, 8:3228-3240.
48. Dhaliwal A., Maldonado M., Lin C., Segura T. Cellular cytoskeleton dynamics modulates non-viral gene delivery through RhoGTPases. PLoS ONE 2012, 7:e35046.
49. Dhaliwal A., Maldonado M., Han Z., Segura T. Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces. Acta Biomater 2010, 6:3436-3447.
50. Riddle K.W., Kong H.J., Leach J.K., Fischbach C., Cheung C., Anseth K.S., Mooney D.J. Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. Mol Ther 2007, 15:361-368.
51. Scheule R.K. The role of CpG motifs in immunostimulation and gene therapy. Adv Drug Deliv Rev 2000, 44:119-134.
52. Gill D.R., Pringle I.A., Hyde S.C. Progress and prospects: the design and production of plasmid vectors. Gene Ther 2009, 16:165-171.
53. Yew N.S., Zhao H., Wu I.H., Song A., Tousignant J.D., Przybylska M., Cheng S.H. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther 2000, 1:255-262.
54. Darquet A.M., Rangara R., Kreiss P., Schwartz B., Naimi S., Delaere P., Crouzet J., Scherman D. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther 1999, 6:209-218.
55. Chen Z.Y., He C.Y., Ehrhardt A., Kay M.A. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 2003, 8:495-500.
56. Asuri P., Bartel M.A., Vazin T., Jang J.-H., Wong T.B., Schaffer D.V. Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells. Mol Ther 2012, 20:329-338.
57. Nguyen A.T., Dow A.C., Kupiec-Weglinski J., Busuttil R.W., Lipshutz G.S. Evaluation of gene promoters for liver expression by hydrodynamic gene transfer. J Surg Res 2008, 148:60-66.
58. Papadakis E.D., Nicklin S.A., Baker A.H., White S.J. Promoters and control elements: designing expression cassettes for gene therapy. Curr Gene Ther 2004, 4:89-113.
59. Koria P. Delivery of growth factors for tissue regeneration and wound healing. BioDrugs 2012, 26:163-175.
60. Scholz C., Wagner E. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. J Control Release 2012, 161:554-565.
61. Morille M., Passirani C., Vonarbourg A., Clavreul A., Benoit J.-P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496.
62. Ginsburg D.S., Thyagarajan B., Phillips J.E., Calos M.P. Gene delivery by viruses. Encyclopedia Life Sci 2005, 1-5.
63. Curtin C.M., Cunniffe G.M., Lyons F.G., Bessho K., Dickson G.R., Duffy G.P., O'Brien F.J. Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient non-viral gene delivery platform for stem cell-mediated bone formation. Adv Mater 2012, 24:749-754.